Beyond hemoglobin (Hb) levels and performance status, further surrogate markers of appropriate transfusion management should improve the quality of thalassemia care. We investigated the levels of peripheral circulating CD34+ stem cells as an independent marker of appropriate hematopoietic balance in patients with thalassemia.
Napolitano, M., Gerardi, C., Di Lucia, A., Accardo, P., Rizzuto, L., Ferraro, M., et al. (2016). Hematopoietic peripheral circulating blood stem cells as an independent marker of good transfusion management in patients with β-thalassemia: results from a preliminary study. TRANSFUSION, n/a-n/a [10.1111/trf.13452].
Hematopoietic peripheral circulating blood stem cells as an independent marker of good transfusion management in patients with β-thalassemia: results from a preliminary study
NAPOLITANO, Mariasanta;SIRAGUSA, Sergio;
2016-01-01
Abstract
Beyond hemoglobin (Hb) levels and performance status, further surrogate markers of appropriate transfusion management should improve the quality of thalassemia care. We investigated the levels of peripheral circulating CD34+ stem cells as an independent marker of appropriate hematopoietic balance in patients with thalassemia.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Accepted proof Transfusion.docx
accesso aperto
Dimensione
48.59 kB
Formato
Microsoft Word XML
|
48.59 kB | Microsoft Word XML | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
